3rd Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2015)

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$600,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Importation; Non-Interference; and Drug Pricing.

Lobbyist	Covered position, as disclosed
JONATHAN DORST New	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—
ALANNA PORTER TEMME	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; Children Health Insurance Program Act of 2015; 21st Century Cures.

Lobbyist	Covered position, as disclosed
JONATHAN DORST New	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—
ALANNA PORTER TEMME	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Transatlantic Trade & Investment Partnership (TTIP) - Proposed Free Trade Agreement between the European Union and the United States (Market Access; Industry-Specific Regulation; Broader Rules and Principles and Modes of Co-operation); TPA, TTP.

Lobbyist	Covered position, as disclosed
ALANNA PORTER TEMME	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); HR 9 - Patent Bill; Healthcare Exchanges; HR 3116 - Modernizing our Drug & Diagnostic Evaluation & Regulatory Network; S.1137 - Patent Act.

Lobbyist	Covered position, as disclosed
JONATHAN DORST New	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—
ALANNA PORTER TEMME	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3116 (114th), H.R. 9 (114th), S. 1137 (114th)

Consumer Issues/Safety/Products CSP

Food and Drug Administration Safety & Innovation Act (FDASIA) [Implementation]; Prescription Drug User Fee Act VI; 21st Century Cures Proposal.

Lobbyist	Covered position, as disclosed
JONATHAN DORST New	—
AMY CHEVALIER EFANTIS	—
JONATHAN REA MCPHERSON	—
ALANNA PORTER TEMME	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE

Animals ANI

Illegal Compounding of Animal Drugs; Vetex Veterinary Biologics, S.1200 - Fairness to Pet Owners Act

Lobbyist	Covered position, as disclosed
JONATHAN DORST New	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1200 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION